Research Overview

Dr. McAdam's research focuses on the utility of diagnostic tests for infections of children.

Education

Medical School

University of Rochester
1995 Rochester NY

Internship

Brigham & Women's Hospital
1996 Boston MA

Residency

Clinical Pathology Brigham & Women's Hospital
1998 Boston MA

Publications

  1. 2024 Acknowledgment of JCM Reviewers. J Clin Microbiol. 2025 Apr 09; 63(4):e0036725. View Abstract
  2. Reaffirming DEI as a central value of JCM. J Clin Microbiol. 2025 May 14; 63(5):e0037225. View Abstract
  3. A call for the United States to continue investing in science. J Bacteriol. 2025 Apr 17; 207(4):e0007225. View Abstract
  4. A call for the United States to continue investing in science. mBio. 2025 Apr 09; 16(4):e0064825. View Abstract
  5. A call for the United States to continue investing in science. mSphere. 2025 Mar 25; 10(3):e0012825. View Abstract
  6. A call for the United States to continue investing in science. J Clin Microbiol. 2025 Apr 09; 63(4):e0034825. View Abstract
  7. A call for the United States to continue investing in science. mSystems. 2025 Apr 22; 10(4):e0027525. View Abstract
  8. A call for the United States to continue investing in science. Clin Microbiol Rev. 2025 Feb 27; e0004425. View Abstract
  9. A call for the United States to continue investing in science. Infect Immun. 2025 Apr 08; 93(4):e0010025. View Abstract
  10. A call for the United States to continue investing in science. Microbiol Mol Biol Rev. 2025 Mar 27; 89(1):e0007225. View Abstract
  11. A call for the United States to continue investing in science. Microbiol Resour Announc. 2025 Apr 10; 14(4):e0019925. View Abstract
  12. A call for the United States to continue investing in science. J Microbiol Biol Educ. 2025 Apr 24; 26(1):e0006725. View Abstract
  13. A call for the United States to continue investing in science. Antimicrob Agents Chemother. 2025 Apr 02; 69(4):e0031925. View Abstract
  14. A call for the United States to continue investing in science. J Virol. 2025 Apr 15; 99(4):e0037625. View Abstract
  15. A call for the United States to continue investing in science. Microbiol Spectr. 2025 Feb 27; e0056825. View Abstract
  16. A call for the United States to continue investing in science. Appl Environ Microbiol. 2025 Apr 23; 91(4):e0046725. View Abstract
  17. 2023 Acknowledgment of JCM Reviewers. J Clin Microbiol. 2024 May 08; 62(5):e0055424. View Abstract
  18. De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen. bioRxiv. 2024 Feb 06. View Abstract
  19. "Innovative Diagnostic Methods," a new section in the Journal of Clinical Microbiology. J Clin Microbiol. 2024 01 17; 62(1):e0141723. View Abstract
  20. The Editors' reply to "Letter responding to performance of updated Enterobacterales piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system". J Clin Microbiol. 2023 11 21; 61(11):e0069223. View Abstract
  21. Antibiotic Therapy for Culture-Proven Bacterial Overgrowth in Children With Intestinal Failure Results in Improved Symptoms and Growth. J Pediatr Gastroenterol Nutr. 2022 09 01; 75(3):345-350. View Abstract
  22. Clinical Laboratory Budgets during the COVID-19 Pandemic: a Micro-Comic Strip. J Clin Microbiol. 2022 03 16; 60(3):e0009622. View Abstract
  23. Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections. Nat Commun. 2022 03 09; 13(1):1231. View Abstract
  24. Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases. Clin Lab Med. 2022 06; 42(2):237-248. View Abstract
  25. Biographical Feature: Andrew B. Onderdonk, Ph.D. J Clin Microbiol. 2021 10 19; 59(11):e0150521. View Abstract
  26. Predictive Value of Direct Disk Diffusion Testing from Positive Blood Cultures in a Children's Hospital and Its Utility in Antimicrobial Stewardship. J Clin Microbiol. 2021 05 19; 59(6). View Abstract
  27. Fun Classifying Fungal Infections: a Micro-Comic Strip. J Clin Microbiol. 2021 04 20; 59(5). View Abstract
  28. Too Slow, Less Dough for SARS-CoV-2 Tests? A Micro-Comic Strip. J Clin Microbiol. 2021 01 21; 59(2). View Abstract
  29. Practice Improvement for Standardized Evaluation and Management of Acute Tracheitis in Mechanically Ventilated Children. Pediatr Qual Saf. 2021 Jan-Feb; 6(1):e368. View Abstract
  30. Can We Test Our Way Out of the COVID-19 Pandemic? J Clin Microbiol. 2020 10 21; 58(11). View Abstract
  31. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Virol. 2020 09 29; 94(20). View Abstract
  32. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Clin Microbiol. 2020 09 22; 58(10). View Abstract
  33. The ASM Journals Committee Values the Contributions of Black Microbiologists. Antimicrob Agents Chemother. 2020 09 21; 64(10). View Abstract
  34. The ASM Journals Committee Values the Contributions of Black Microbiologists. Infect Immun. 2020 09 18; 88(10). View Abstract
  35. The ASM Journals Committee Values the Contributions of Black Microbiologists. Mol Cell Biol. 2020 09 14; 40(19). View Abstract
  36. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Bacteriol. 2020 09 08; 202(19). View Abstract
  37. The ASM Journals Committee Values the Contributions of Black Microbiologists. Appl Environ Microbiol. 2020 09 01; 86(18). View Abstract
  38. Is This a Critical Result? A Micro-Comic Strip. J Clin Microbiol. 2020 08 24; 58(9). View Abstract
  39. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Resour Announc. 2020 Jul 31; 9(32). View Abstract
  40. The ASM Journals Committee Values the Contributions of Black Microbiologists. J Microbiol Biol Educ. 2020; 21(2). View Abstract
  41. The ASM Journals Committee Values the Contributions of Black Microbiologists. mSphere. 2020 07 31; 5(4). View Abstract
  42. The ASM Journals Committee Values the Contributions of Black Microbiologists. mSystems. 2020 Jul 31; 5(4). View Abstract
  43. The ASM Journals Committee Values the Contributions of Black Microbiologists. mBio. 2020 07 31; 11(4). View Abstract
  44. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Mol Biol Rev. 2020 08 19; 84(3). View Abstract
  45. The ASM Journals Committee Values the Contributions of Black Microbiologists. Clin Microbiol Rev. 2020 09 16; 33(4). View Abstract
  46. What Is Needed for the Response to COVID-19? A Micro-Comic Strip. J Clin Microbiol. 2020 Jul 23; 58(8). View Abstract
  47. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic. J Clin Microbiol. 2020 Jul 23; 58(8). View Abstract
  48. The ASM Journals Committee Values the Contributions of Black Microbiologists. Microbiol Spectr. 2020 07; 8(3). View Abstract
  49. Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19. Pediatr Pulmonol. 2020 09; 55(9):2213-2224. View Abstract
  50. The Clinical Microbiology Laboratory Response to COVID-19: a Micro-Comic Strip. J Clin Microbiol. 2020 05 26; 58(6). View Abstract
  51. What's Special about Cefiderocol? A Micro-Comic Strip. J Clin Microbiol. 2020 04 23; 58(5). View Abstract
  52. The End of Coagulase-Negative Staphylococci? A Micro-Comic Strip. J Clin Microbiol. 2020 02 24; 58(3). View Abstract
  53. The genome of opportunistic fungal pathogen Fusarium oxysporum carries a unique set of lineage-specific chromosomes. Commun Biol. 2020 01 31; 3(1):50. View Abstract
  54. Enterobacteriaceae? Enterobacterales? What Should We Call Enteric Gram-Negative Bacilli? A Micro-Comic Strip. J Clin Microbiol. 2020 01 28; 58(2). View Abstract
  55. Are Bacteria Sensitive or Susceptible? A Micro-Comic Strip. J Clin Microbiol. 2019 12 23; 58(1). View Abstract
  56. Don't Test Me: a Micro-Comic Strip. J Clin Microbiol. 2019 12; 57(12). View Abstract
  57. Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med. 2019 11; 25(11):1728-1732. View Abstract
  58. What's That Species? A Micro-Comic Strip. J Clin Microbiol. 2019 11; 57(11). View Abstract
  59. Total Laboratory Automation: a Micro-Comic Strip. J Clin Microbiol. 2019 10; 57(10). View Abstract
  60. What about Serology? A Micro-Comic Strip. J Clin Microbiol. 2019 09; 57(9). View Abstract
  61. Reply to Molitor, "Susceptibility Categories Should Be Agreed Upon". J Clin Microbiol. 2019 09; 57(9). View Abstract
  62. The Photo Quiz: a Look Back and a Look Forward. J Clin Microbiol. 2019 09; 57(9). View Abstract
  63. Improving the Laboratory Information System: a Micro-Comic Strip. J Clin Microbiol. 2019 08; 57(8). View Abstract
  64. Can You Speciate This for Me? A Micro-Comic Strip. J Clin Microbiol. 2019 07; 57(7). View Abstract
  65. What Is the Future of Clinical Microbiology? Clin Lab Med. 2019 09; 39(3):509-512. View Abstract
  66. Epidemiological Cutoff Values: a Micro-Comic Strip. J Clin Microbiol. 2019 06; 57(6). View Abstract
  67. Biographical Feature: Stephen G. Jenkins, Ph.D., D(ABMM), F(AAM). J Clin Microbiol. 2019 05; 57(5). View Abstract
  68. The Significance of Microbial Taxonomy: a Micro-Comic Strip. J Clin Microbiol. 2019 05; 57(5). View Abstract
  69. The Divergent Meanings of "I" for the Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility Testing: a Micro-Comic Strip. J Clin Microbiol. 2019 04; 57(4). View Abstract
  70. Whole-Genome Sequences of Staphylococcus aureus Isolates from Cystic Fibrosis Lung Infections. Microbiol Resour Announc. 2019 Jan; 8(3). View Abstract
  71. Rebranding Clinical Laboratories: a Micro-Comic Strip. J Clin Microbiol. 2019 01; 57(1). View Abstract
  72. Pitfalls in Performing Research in the Clinical Microbiology Laboratory: a Micro-Comic Strip. J Clin Microbiol. 2018 10; 56(10). View Abstract
  73. Shotgun Metagenomic Detection of Pathogens: a Micro-Comic Strip. J Clin Microbiol. 2018 08; 56(8). View Abstract
  74. Winners of the American Society for Microbiology Awards in Clinical Microbiology. J Clin Microbiol. 2018 06; 56(6). View Abstract
  75. Paying for Point-of-Care Nucleic Acid Amplification Tests: a Micro-Comic Strip. J Clin Microbiol. 2018 06; 56(6). View Abstract
  76. Total Laboratory Automation in Clinical Microbiology: a Micro-Comic Strip. J Clin Microbiol. 2018 04; 56(4). View Abstract
  77. The Utility of Multiplex Molecular Tests for Enteric Pathogens: a Micro-Comic Strip. J Clin Microbiol. 2018 02; 56(2). View Abstract
  78. The Role of Scientific and Medical Societies in Journals … and More: a Micro-Comic Strip. J Clin Microbiol. 2017 12; 55(12):3315. View Abstract
  79. Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis. J Cyst Fibros. 2018 05; 17(3):e25-e31. View Abstract
  80. Sensitivity and Specificity or Positive and Negative Percent Agreement? A Micro-Comic Strip. J Clin Microbiol. 2017 11; 55(11):3153-3154. View Abstract
  81. Discrepant Analysis and Bias: a Micro-Comic Strip. J Clin Microbiol. 2017 10; 55(10):2878-2879. View Abstract
  82. Prevalence and Predictive Values: a Micro-Comic Strip. J Clin Microbiol. 2017 09; 55(9):2566. View Abstract
  83. Reducing Contamination of Blood Cultures: Consider Costs and Clinical Benefits. Clin Infect Dis. 2017 07 15; 65(2):206-207. View Abstract
  84. Unforeseen Consequences: Culture-Independent Diagnostic Tests and Epidemiologic Tracking of Foodborne Pathogens. J Clin Microbiol. 2017 07; 55(7):1978-1979. View Abstract
  85. Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung. Nat Commun. 2017 01 19; 8:14078. View Abstract
  86. A Rose by Any Other Name: Practical Updates on Microbial Nomenclature for Clinical Microbiology. J Clin Microbiol. 2017 01; 55(1):3-4. View Abstract
  87. Association Between Storage Interval and Contamination of Reprocessed Flexible Endoscopes in a Pediatric Gastrointestinal Procedural Unit. Infect Control Hosp Epidemiol. 2017 02; 38(2):131-135. View Abstract
  88. ASM Journals Eliminate Impact Factor Information from Journal Websites. Clin Microbiol Rev. 2016 10; 29(4):i-ii. View Abstract
  89. ASM Journals Eliminate Impact Factor Information from Journal Websites. Appl Environ Microbiol. 2016 09 15; 82(18):5479-80. View Abstract
  90. The Focus on Quality Publications in Journal of Clinical Microbiology. J Clin Microbiol. 2016 09; 54(9):2218. View Abstract
  91. ASM Journals Eliminate Impact Factor Information from Journal Websites. Antimicrob Agents Chemother. 2016 09; 60(9):5109-10. View Abstract
  92. ASM Journals Eliminate Impact Factor Information from Journal Websites. Infect Immun. 2016 09; 84(9):2407-8. View Abstract
  93. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatr Int Child Health. 2016 Aug; 36(3):189-97. View Abstract
  94. Essential Microbiology for Wound Care. Clin Infect Dis. 2016 Oct 15; 63(8):1149. View Abstract
  95. ASM Journals Eliminate Impact Factor Information from Journal Websites. Microbiol Mol Biol Rev. 2016 09; 80(3):i-ii. View Abstract
  96. ASM Journals Eliminate Impact Factor Information from Journal Websites. mBio. 2016 07 11; 7(4). View Abstract
  97. ASM Journals Eliminate Impact Factor Information from Journal Websites. mSphere. 2016 Jul-Aug; 1(4). View Abstract
  98. ASM Journals Eliminate Impact Factor Information from Journal Websites. mSystems. 2016 Jul-Aug; 1(4). View Abstract
  99. ASM Journals Eliminate Impact Factor Information from Journal Websites. J Clin Microbiol. 2016 09; 54(9):2216-7. View Abstract
  100. Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents. Clin Infect Dis. 2016 10 01; 63(7):922-8. View Abstract
  101. The Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water. J Clin Microbiol. 2016 06; 54(6):1414-1415. View Abstract
  102. Closing the Brief Case: Safe To Go Back in the Water? Vibrio parahaemolyticus Wound Infection Associated with Brackish Water. J Clin Microbiol. 2016 06; 54(6):1672. View Abstract
  103. Pediatric Clinical Microbiology: It's the Little Things. J Clin Microbiol. 2016 06; 54(6):1412-1413. View Abstract
  104. Reply to "Case Reports May Be Declared Dead by the Journal of Clinical Microbiology, but They Are Alive and Well in JMM Case Reports". J Clin Microbiol. 2016 Feb; 54(2):503. View Abstract
  105. The Brief Case: a New Feature in Journal of Clinical Microbiology. J Clin Microbiol. 2016 Mar; 54(3):512. View Abstract
  106. Your Viral Past: A Comprehensive Method for Serological Profiling to Explore the Human Virome. Clin Chem. 2016 Mar; 62(3):426-7. View Abstract
  107. An Obituary for the Case Report in Journal of Clinical Microbiology. J Clin Microbiol. 2015 Aug; 53(8):2396-7. View Abstract
  108. The aetiology of diarrhoea, pneumonia and respiratory colonization of HIV-exposed infants randomized to breast- or formula-feeding. Paediatr Int Child Health. 2015 Jun 8; 2046905515Y0000000038. View Abstract
  109. Preface. Diagnostic testing for enteric pathogens. Clin Lab Med. 2015 Jun; 35(2):xi-xii. View Abstract
  110. Shiga Toxin Producing Escherichia coli. Clin Lab Med. 2015 Jun; 35(2):247-72. View Abstract
  111. Point-Counterpoint: Large Multiplex PCR Panels Should Be First-Line Tests for Detection of Respiratory and Intestinal Pathogens. J Clin Microbiol. 2015 Oct; 53(10):3110-5. View Abstract
  112. A happy birthday and a transition at the Journal of Clinical Microbiology. J Clin Microbiol. 2015 Jan; 53(1):2-3. View Abstract
  113. What's your subtype? The epidemiologic utility of bacterial whole-genome sequencing. Clin Chem. 2014 Apr; 60(4):586-8. View Abstract
  114. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat Genet. 2014 Jan; 46(1):82-7. View Abstract
  115. Yield of fungal surveillance cultures in pediatric hematopoietic stem cell transplant patients: a retrospective analysis and survey of current practice. Clin Infect Dis. 2014 Feb; 58(3):365-71. View Abstract
  116. Interferon ?-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons. Clin Chem. 2014 May; 60(5):714-8. View Abstract
  117. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013 Sep; 57(3):293-7. View Abstract
  118. Biographical feature: Eileen L. Randall, Ph.D. J Clin Microbiol. 2013 Nov; 51(11):3476-7. View Abstract
  119. Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures? Clin Chem. 2013 Nov; 59(11):1556-60. View Abstract
  120. Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units. Epidemiol Infect. 2013 Sep; 141(9):1983-92. View Abstract
  121. Hand, foot, and mouth disease caused by coxsackievirus a6. Emerg Infect Dis. 2012 Oct; 18(10):1702-4. View Abstract
  122. John C. Sherris, M.D. J Clin Microbiol. 2012 Nov; 50(11):3416-7. View Abstract
  123. Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study. Pediatr Infect Dis J. 2012 Jul; 31(7):767-9. View Abstract
  124. Antibiotic resistance: how serious is the problem, and what can be done? Clin Chem. 2012 Aug; 58(8):1182-6. View Abstract
  125. Impact of in-hospital enteroviral polymerase chain reaction testing on the clinical management of children with meningitis. J Hosp Med. 2012 Sep; 7(7):517-20. View Abstract
  126. Photo quiz: an 11-year-old with abdominal pain. J Clin Microbiol. 2012 Apr; 50(4):1139, 1508. View Abstract
  127. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis. 2012 Jun; 205(11):1709-18. View Abstract
  128. Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. J Clin Microbiol. 2012 Jun; 50(6):1836-40. View Abstract
  129. A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity. PLoS One. 2012; 7(2):e31307. View Abstract
  130. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet. 2011 Nov 13; 43(12):1275-80. View Abstract
  131. Improved sensitivity of a commercial reverse transcription-PCR test for subtyping of the 2009 H1N1 influenza A virus. J Clin Microbiol. 2011 Mar; 49(3):1188. View Abstract
  132. Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol. 2011 Mar; 49(3):955-9. View Abstract
  133. Streptococcus milleri group pleuropulmonary infection in children: computed tomographic findings and clinical features. J Comput Assist Tomogr. 2010 Nov-Dec; 34(6):927-32. View Abstract
  134. Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care units. J Clin Microbiol. 2010 Aug; 48(8):2957-9. View Abstract
  135. Trimethoprim in vitro antibacterial activity is not increased by adding sulfamethoxazole for pediatric Escherichia coli urinary tract infection. J Urol. 2010 Jul; 184(1):305-10. View Abstract
  136. Multicenter study of clinical performance of the 3M Rapid Detection RSV test. J Clin Microbiol. 2010 Jul; 48(7):2337-43. View Abstract
  137. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine. 2010 Jul 05; 28(30):4842-6. View Abstract
  138. Test characteristics of commercial influenza assays for detecting pandemic influenza A (H1N1) in children. Pediatr Infect Dis J. 2010 Mar; 29(3):261-2. View Abstract
  139. Human metapneumovirus. Clin Lab Med. 2010 Mar; 30(1):131-48. View Abstract
  140. Swine-origin influenza a (H1N1) viral infection in children: initial chest radiographic findings. Radiology. 2010 Mar; 254(3):934-41. View Abstract
  141. Respiratory viruses in pediatric and adult populations. Preface. Clin Lab Med. 2009 Dec; 29(4):xi-xii. View Abstract
  142. Developments in tissue culture detection of respiratory viruses. Clin Lab Med. 2009 Dec; 29(4):623-34. View Abstract
  143. Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics. 2009 Dec; 124(6):e1072-80. View Abstract
  144. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis. 2009 Jul 11; 9:110. View Abstract
  145. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med. 2008 Feb; 15(2):111-8. View Abstract
  146. Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol. 2007 Jun; 45(6):1684-9. View Abstract
  147. Influenza and other respiratory virus-related emergency department visits among young children. Pediatrics. 2006 Jul; 118(1):e1-8. View Abstract
  148. Validation of syndromic surveillance for respiratory infections. Ann Emerg Med. 2006 Mar; 47(3):265.e1. View Abstract
  149. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med. 2006 Feb 15; 173(4):421-5. View Abstract
  150. Cerebrospinal latex agglutination fails to contribute to the microbiologic diagnosis of pretreated children with meningitis. Pediatr Infect Dis J. 2004 Aug; 23(8):786-8. View Abstract
  151. Pathology of human metapneumovirus infection: insights into the pathogenesis of a newly identified respiratory virus. Pediatr Dev Pathol. 2004 Sep-Oct; 7(5):478-86; discussion 421. View Abstract
  152. Human metapneumovirus in children tested at a tertiary-care hospital. J Infect Dis. 2004 Jul 01; 190(1):20-6. View Abstract
  153. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol. 2004 Apr; 42(4):1559-63. View Abstract
  154. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004 Mar; 113(3 Pt 1):585-93. View Abstract
  155. Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol. 2004 Mar; 42(3):1263-4. View Abstract
  156. Human metapneumovirus--an important new respiratory virus. N Engl J Med. 2004 Jan 29; 350(5):431-3. View Abstract
  157. Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. J Immunol. 2002 Feb 01; 168(3):991-5. View Abstract
  158. ICOS is critical for CD40-mediated antibody class switching. Nature. 2001 Jan 04; 409(6816):102-5. View Abstract
  159. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol. 2000 Nov 01; 165(9):5035-40. View Abstract
  160. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL. J Immunol. 2000 Sep 15; 165(6):3088-93. View Abstract
  161. Discrepant analysis: how can we test a test? J Clin Microbiol. 2000 Jun; 38(6):2027-9. View Abstract
  162. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J Virol. 2000 Jan; 74(1):203-8. View Abstract
  163. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity. 1999 Dec; 11(6):689-98. View Abstract
  164. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol. 1999 Oct 01; 163(7):3753-7. View Abstract
  165. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med. 1999 Jan 18; 189(2):435-40. View Abstract
  166. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev. 1998 Oct; 165:231-47. View Abstract
  167. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes. J Immunol. 1998 Jun 15; 160(12):5773-80. View Abstract
  168. Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes. Cancer Immunol Immunother. 1996 Jul; 42(6):362-8. View Abstract
  169. Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor. Cell Immunol. 1995 Oct 15; 165(2):183-92. View Abstract
  170. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell Immunol. 1995 Oct 15; 165(2):217-24. View Abstract
  171. Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells. Int J Cancer. 1995 May 29; 61(5):628-34. View Abstract
  172. Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes. J Immunother Emphasis Tumor Immunol. 1994 Apr; 15(3):155-64. View Abstract
  173. Isolation and expansion of tumor-infiltrating lymphocytes. Biotechniques. 1993 Dec; 15(6):970-2. View Abstract
  174. Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2. J Immunother Emphasis Tumor Immunol. 1993 Nov; 14(4):293-7. View Abstract
  175. Coexpression of IL-2 and gamma-IFN enhances tumor immunity. Ann N Y Acad Sci. 1993 Aug 12; 690:349-51. View Abstract
  176. Transfection of TGF-beta producing tumors with IL-2 elicits tumor rejection. Ann N Y Acad Sci. 1993 Aug 12; 690:346-8. View Abstract
  177. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res. 1993 May 01; 53(9):2112-7. View Abstract
  178. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone. Eur J Immunol. 1992 Sep; 22(9):2461-4. View Abstract
  179. Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumor. J Immunol. 1991 Aug 15; 147(4):1433-8. View Abstract
  180. Class-I MHC expression in the mouse lung carcinoma, line 1: a model for class-I inducible tumors. Int J Cancer Suppl. 1991; 6:82-9. View Abstract
  181. Thyroid hormone status regulates preprotachykinin-A gene expression in male rat anterior pituitary. Endocrinology. 1987 Oct; 121(4):1555-61. View Abstract

Contact Alexander McAdam

Print Profile